Publications of K. T. Pan

Göllner, S.; Agrawal-Singh, S.; Oellerich, T.; Schenk, T.; Rohde, C.; Klein, H. U.; Sauer, T.; Lerdrup, M.; Tavor, S.; Stölzel, F. et al.; Ehninger, G.; Köhler, G.; Pan, K. T.; Urlaub, H.; Serve, H.; Dugas, M.; Berdel, W. E.; Hansen, K.; Zelent, A.; Thiede, C.; Müller-Tidow, C.: A novel epigenetic resistance mechanism to the FLT3 inhibitor PK412 induces cross-resistance to standard chemotherapy in acute myeloid leukemia (AML). 21st Congress of the European-Hematology-Association, Copenhagen, Denmark, June 09, 2016 - June 12, 2016. Haematologica 101 (Suppl. 1), p. 166 - 166 (2016)

Ten Hacken, E.; Oellerich, T.; Gounari, M.; Pan, K. T.; Wierda, W. G.; Ferrajoli, A.; Estrov, Z.; Keating, M. J.; Urlaub, H.; Ghia, P. et al.; Burger, J. A.: Identification of novel B cell receptor antigens in chronic lymphocytic leukemia. 21st Congress of the European-Hematology-Association, Copenhagen, Denmark, June 09, 2016 - June 12, 2016. Haematologica 101 (Suppl. 1), p. 45 - 45 (2016)

ten Hacken, E.; Oellerich, T.; Gounari, M.; Hoellenriegel, J.; Pan, K. T.; O'Brien, S.; Wierda, W.; Ferrajoli, A.; Estrov, Z.; Keating, M. J. et al.; Urlaub, H.; Ghia, P.; Burger, J. A.; JA: Identification of B cell receptor antigens in the chronic lymphocytic leukemia microenvironment. 57th Annual Meeting of the American-Society-of-Hematology, Orlando, FL, December 05, 2015 - December 08, 2015. Blood 126 (23), (2015)

Bohnenberger , H.; Yepes , D.; Pan, K. T.; Emmert, A.; Henric-Petri , H.; Bremmer, F.; Strecker , J.; Lois , A. M.; Fischer, L.; Kuffer , S. et al.; Hinterthaner, M.; Wolff, H.; Canis , M.; Sebastian , M.; Danner, B.; Strobel, P.; Serve, H.; Urlaub, H.; Oellerich, T.: Proteomic profiling of pulmonary cancer with squamous cell histology. Journal of Thoracic Oncology 10 (Suppl. 2), 9 Ed., pp. S293 - 293 (2015)

Oellerich, T.; Corso, J.; Beck, J.; Pan, K. T.; Doebele, C.; Wachter, A.; Lenz, C.; Beissbarth, T.; Schuetz, E.; Tomska, K. et al.; Sellner, L.; Zenz, T.; Serve, H.; Urlaub, H.: The B cell reseptor signaling output in Burkitt´s lymphoma is genotype specific and impacts sensitivity towards BCR signaling inhibitors. 20th Congress of the European Hematology Association , Vienna, Austria, June 11, 2015 - June 14, 2015. Haematologica 100 (Suppl. 1), p. 178 - 178 (2015)